European Journal of Cancer
Volume 33, Issue 5 , Pages 727-734 , April 1997

The genetic basis of human keratinocyte immortalisation in squatnous cell carcinoma development: The role of telomerase reactivation

  • E.K. Parkinson

      Affiliations

    • Beatson Institute for Cancer Research, CRC Beatson Laboratories, Garscube Estate, Switchback Road, Bearsden, Glasgow G61 1BD, U.K.
    • Corresponding Author InformationCorrespondence to E. K. Parkinson.
    • ,
  • R.F. Newbold

      Affiliations

    • Department of Biology and Biochemistry, Brunei University, Uxbridge UB8 3PH, Middlesex, U.K.
    • ,
  • W.N. Keith

      Affiliations

    • University of Glasgow Department of Medical Oncology, CRC Beatson Laboratories, Garscube Estate, Switchback Road, Bearsden, Glasgow G61 1BD, U.K.

References 

  1. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res. 1965;37:614–636
  2. Rheinwald JG, Green H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell. 1975;6:331–343
  3. Wille JJ, Pittelkow MR, Shipley GD, Scott RE. Integrated control of growth and differentiation of normal human prokeratinocytes cultured in serumfree medium: clonal analyses, growth kinetics, and cell cycle studies. J Cell Physiol. 1984;121:31–44
  4. Barrandon Y, Green H. Three clonal types of keratinocyte with different capacities for multiplication. In: Proc Natl Acad Sci USA. 84:1987;p. 2302–2306
  5. Dimri GP, Lee X, Basile G, et al. A biomarker that identifies senescent human cells in culture and in ageing skin in vivo. In: Proc Natl Acad Sci USA. 92:1995;p. 9863–9867
  6. Edington KG, Loughran OP, Berry JJ, Parkinson EK. Cellular immortality: a late event in the progression of human squamous cell carcinoma of the head and neck associated with p53 alteration and a high frequency of allele loss. Mol Carcinogenesis. 1995;13:254–265
  7. Watson JD. Origin of concatameric T7 DNA. Nature New Biol. 1972;239:197–201
  8. Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell. 1995;81:405–413
  9. Wright WE, Piatyszek MA, Rainey WE, Byrd JW, Shay JW. Telomerase activity in human germline and embryonic tissues and cells. Dev Genet. 1996;18:173–179
  10. Harley CB, Futcher GB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature. 1990;345:458–460
  11. de Lange T. Activation of telomerase in a human tumor. In: Proc Natl Acad Sci USA. 91:1994;p. 2882–2885
  12. Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. In: Proc Natl Acad Sci USA. 91:1994;p. 9857–9860
  13. Wainwright LJ, Middleton PG, Rees JL. Changes in mean telomere length in basal cell carcinomas of the skin. Genes Chromosomes Cancer. 1995;12:45–49
  14. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC. Telomere reduction in human colorectal carcinoma and with ageing. Nature. 1990;346:866–868
  15. Wright WE, Brasiskyte D, Piatyszek MA, Shay JW. Experimental elongation of telomeres extends the lifespan of immortal × normal cell hybrids. EMBO J. 1996;15:1734–1741
  16. Harle-Bachor C, Boukamp P. Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinomaderived skin keratinocytes. In: Proc Natl Acad Sci USA. 93:1996;p. 6476–6481
  17. Yasumoto S, Kunimara C, Kikuchi K, et al. Telomerase activity in normal human epithelial cells. Oncogens. 1996;13:433–439
  18. Jones PH, Watt FM. Stem cell patterning and fate in human epidermis. Cell. 1995;80:83–93
  19. Holt SE, Shay JW, Wright WE. Refining the telomere-telomerase hypothesis of ageing and cancer. Nature Biotech. 1996;14:836–839
  20. von Zglinicki T, Saretzki G, Docke W, Lotze C. Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: a model for senescence?. Exp Cell Res. 1995;220:186–193
  21. Orr WC, Sohal RS. Extension of lifespan by overexpression of Superoxide dismutase and catalase in Drosophila melanogaster. Science. 1994;263:1128–1130
  22. Lithgow GJ, White TM, Melov S, Johnson TE. Thermotolerance and extended lifespan conferred by single gene mutations and induced by thermal stress. In: Proc Natl Acad Sci USA. 92:1995;p. 7540–7544
  23. Saito H, Hammond AT, Moses RE. The effect of low oxygen tension on the in vitro replicative life span of human diploid fibroblast cells and their transformed derivatives. Exp Cell Res. 1995;217:272–279
  24. Davidson JF, Whyte B, Bissinger PH, Schiestl RH. Oxidative stress is involved in heatinduced cell death in Saccharomyces cerevisiae. In: Proc Natl Acad Sci USA. 93:1996;p. 5116–5121
  25. Thompson KVA, Holliday R. Effect of temperature on the longevity of human fibroblasts in culture. Exp Cell Res. 1973;80:354–360
  26. Shiloh Y. Ataxia-telangiectasia: closer to unravelling the mystery. Eur J Hum Genet. 1995;3:116–138
  27. Metcalf JA, Parkhill J, Campbell L, et al. Accelerated telomeric shortening in ataxia telangiectasia. Nature Genet. 1996;13:350–353
  28. Greenwell PW, Kronmal SL, Porter SE, Gassenhuber J, Obermaier B, Petes TD. TEL1, a gene involved in controlling telomere length in S. cerevisiae, is homologous to the human ataxia telangiectasia gene. Cell. 1995;82:823–829
  29. Vaziri H, Schacter F, Uchida I, et al. Loss of telomeric DNA during ageing of normal and trisomy 21 human lymphocytes. Am J Hum Genet. 1993;52:661–667
  30. Cossarizza A, Ortolani C, Forti E, et al. Agerelated expansion of functionally inefficient cells with markers of natural killer activity in Down's syndrome. Blood. 1991;77:1263–1270
  31. Ceballos-Picot I, Nicole A, Sinet PM. Cellular clones and transgenic mice overexpressing copperzinc superoxide dismutase: models for the study of free radical metabolism and ageing. EXS. 1992;62:89–98
  32. Yu CE, Oshima J, Fu Y-H, et al. Positional cloning of the Werner's syndrome gene. Science. 1996;272:258–262
  33. Kruk PA, Rampino NJ, Bohr VA. DNA damage and repair in telomeres: relation to ageing. In: Proc Natl Acad Sci USA. 92:1995;p. 258–262
  34. Smith JR, Whitney RG. Intraclonal variation in proliferation potential of human diploid fibroblasts: stochastic mechanism for cellular ageing. Science. 1980;207:82–84
  35. Sandell LL, Zakian VA. Loss of yeast telomere: arrest, recovery, and chromosome loss. Cell. 1993;75:729–739
  36. Stein GL, Dulic V. Origins of G1 arrest in senescent human fibroblasts. Bioessays. 1995;17:537–543
  37. Maity A, McKenna WG, Muschel RJ. The molecular basis for cell cycle delays following ionizing radiation: a review. Radiat Oncol. 1994;31:1–13
  38. Atadja P, Wong H, Garkavtsev I, Veilette C, Riabowol K. Increased activity of p53 in senescing fibroblasts. In: Proc Natl Acad Sci USA. 92:1995;p. 8348–8352
  39. Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR. Cloning of senescent cellderived inhibitors of DNA synthesis using an expression screen. Exp Cell Res. 1994;211:90–98
  40. Dulic V, Drullinger LF, Lees E, Reed SI, Stein GH. Altered regulation of G1 cyclins in senescent human diploid fibroblasts: accumulation of inactive cyclin E-Cdk2 and cyclin D1-Cdk2 complexes. In: Proc Natl Acad Sci USA. 90:1993;p. 11034–11038
  41. Stein GH, Beeson M, Gordon L. Failure to phosphorylate the retinoblastoma gene product in senescent human fibroblasts. Science. 1990;249:666–669
  42. Cristofalo V, Sharf BB. Cellular senescence and DNA synthesis: thymidine incorporation as a measure of population age in human diploid cells. Exp Cell Res. 1973;76:419–427
  43. Hara E, Smith R, Parry D, Tahara H, Stone S, Peters G. Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol Cell Biol. 1996;16:859–867
  44. Loughran O, Malliri A, Owens D, et al. Association of CDKN2A/p16INK4A with human keratinocyte replicative senescence: relationship of dysfunction to immortality and neoplasia. Oncogene. 1996;13:561–567
  45. Koh J, Enders GH, Dynlacht BD, Harlow E. Tumourderived p16 alleles encoding proteins defective in cell cycle inhibition. Nature. 1995;375:506–510
  46. Reznikoff CA, Yeager TR, Belair CD, Savelieva E, Puthenveettil JA, Stadler WM. Elevated p16 at senescence and loss of p16 at immortalization in human papillomavirus 16 E6, but not E7, transformed human uroepithelial cells. Cancer Res. 1996;56:2886–2890
  47. Kennedy BK, Austriaco NR, Zhang J, Guarante L. Mutation in the silencing gene SIR4 can delay ageing in S. cerevisiae. Cell. 1995;80:485–496
  48. Marcand S, Buck SW, Moretti P, Gilson E, Shore D. Silencing of genes at nontelomeric sites in yeast is controlled by sequestration of silencing factors at telomeres by RAP 1 protein. Genes Dev. 1996;10:1297–1309
  49. Seshradi T, Campisi J. Repression of c-fos transcription and an altered genetic program in senescent human fibroblasts. Science. 1990;247:205–209
  50. Hara E, Tsuri H, Shinozaki A, Nakada S, Oda K. Cooperative effect of antisense-Rb and antisense-p53 oligomers on the extension of lifespan in human diploid fibroblasts, TIG-1. Biochem Biophys Res Comm. 1991;179:528–534
  51. Shay JW, Pereira-Smith OM, Wright WE. A role for both RB and p53 regulation of human cellular senescence. Exp Cell Res. 1991;196:33–40
  52. Counter CM, Avilion AA, LeFeuvre CE, et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 1992;11:1921–1929
  53. Wright WE, Pereira-Smith OM, Shay JW. Reversible cellular sensecence: implications for immortalization of normal human diploid fibroblasts. Mol Cell Biol. 1989;9:3088–3092
  54. Radna RL, Caton Y, Jha KK, et al. Growth of immortal Simian virus 40 tsA-transformed fibroblasts is temperature dependent. Mol Cell Biol. 1989;9:3093–3096
  55. Rheinwald JG, Beckett MA. Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas. Cancer Res. 1981;41:1657–1663
  56. Shay JW, Wright WE. The reactivation of telomerase activity in cancer progression. Trends Genet. 1996;12:129–131
  57. Yin Y, Tainsky MA, Bischoff FZ, Strong LC, Wahl GM. Wild type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell. 1992;70:937–948
  58. Wiesmuller L, Cammenga J, Deppert WW. In vivo assay of p53 function in homologous recombination between simian virus 40 chromosomes. J Virol. 1996;70:737–744
  59. Carder P, Wyllie AH, Purdie CA, et al. Stabilised p53 facilitates aneuploid clonal divergence in colorectal cancer. Oncogene. 1993;8:1397–1401
  60. Wynford-Thomas D, Bond JA, Wyllie FS, Jones CJ. Does telomere shortening drive selection for p53 mutation in human cancer?. Mol Carcinogenesis. 1995;12:119–123
  61. Shay JW, Wright WE, Werbin H. Loss of telomeric DNA during ageing may predispose cells to cancer. Int J Oncol. 1993;3:559–563
  62. Loughran O, Edington KG, Berry IJ, Clarke LJ, Parkinson EK. Loss of heterozygosity of chromosome 9p21 is associated with the immortal phenotype of neoplastic human head and neck keratinocytes. Cancer Res. 1994;54:5045–5049
  63. Cairns P, Ploascik TJ, Eby Y. Frequency of homozygous deletion at p16/cdkn2 in primary human tumors. Nature Genet. 1995;11:210–212
  64. Merlo A, Herman JG, Mao J, et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/cdkn2/mts1 in human cancers. Nat Med. 1995;1:686–692
  65. Reed AL, Califano J, Cairns P, et al. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res. 1996;56:3630–3633
  66. Pereira-Smith OM, Smith JR. Genetic analysis of indefinite division in human cells: identification of four complementation groups. In: Proc Natl Acad Sci USA. 85:1988;p. 6042–6046
  67. Ning Y, Weber JL, Killary AM, Ledbetter DH, Smith JR, Pereira-Smith OM. Genetic analysis of indefinite division in human cells: evidence for a cell senescencerelated gene (s) on human chromosome 4. In: Proc Natl Acad Sci USA. 88:1991;p. 5635–5639
  68. Hensler PJ, Annab LA, Barrett JC, Pereira-Smith OM. A gene involved in control of cellular senescence on human chromosomes 1q. Mol Cell Biol. 1994;14:2291–2297
  69. Ogata T, Auysawa D, Namba M, Takahashi E, Oshimura M, Oishi M. Chromosome 7 suppresses indefinite division of nontumorigenic immortalized human fibroblast cell lines KMST-6 and SUSM-1. Mol Cell Biol. 1993;13:6036–6043
  70. Loughran O, Clark LJ, Bond J, et al. Evidence for the inactivation of multiple replicative lifespan genes in immortal human squamous cell carcinoma keratinocytes. Oncogene, in press.
  71. Kim NW, Piatyszak MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science. 1994;266:2011–2014
  72. Feng J, Funk WD, Wang S-S, et al. The RNA component of human telomerase. Science. 1995;269:1236–1241
  73. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW. Correlating telomerase activity levels with human neuroblastoma outcomes. Nat Med. 1995;1:249–255
  74. Greaves M. Is telomerase activity in cancer due to selection of stem cells and differentiation arrest?. Trends Genet. 1996;12:127–128
  75. Taylor RS, Ramirez RD, Ogoshi M, Chaffins M, Piatyszek MA, Shay JW. Detection of telomerase activity in malignant and non malignant skin conditions. J Invest Dermatol. 1996;106:759–765
  76. Hiyama K, Hiyama E, Ishoika S. Telomerase activity in small-cell and non-small-cell lung cancers. J Natl Cancer Inst. 1995;87:895–902
  77. Ohmura H, Tahara H, Suzuki M. Restoration of the cellular senescence program and repression of telomerase by chromosome 3. Jpn J Cancer Res. 1995;86:899–904
  78. Speicher MR, Howe C, Crotty P, Du Manoir S, Costa J, Ward DC. Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinomas. Cancer Res. 1995;55:1010–1013
  79. Hermsen MAJA, Joenje H, Arwert F, et al. Centromeric breakage as a major cause of cytogenetic abnormalities in oral squamous cell carcinoma. Genes Chromosomes Cancer. 1996;15:1–9
  80. Soder AI, Hoare SF, Muire S, Going JJ, Parkinson EK, Keith WN. Amplification and increased gene dosage of the telomerase RNA gene in human cancer. Oncogene, in press.
  81. Avilion AA, Piatyszek MA, Gupta J, Shay JW, Bacchetti S, Greider CW. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res. 1996;56:645–650

PII: S0959-8049(97)00063-4

doi: 10.1016/S0959-8049(97)00063-4

European Journal of Cancer
Volume 33, Issue 5 , Pages 727-734 , April 1997

Article Tools